Cancer Treatment as a Double-Edged Sword
American Technion SocietyFindings by cancer researchers at the Technion-Israel Institute of Technology shed new light on why treated cancers recur. The discovery could provide the key for reducing recurrence, and allow anti-cancer drugs to do their intended work.